Jurkat T cells were early on used to decipher the fundamental molecular biology of TCR/CD3 signaling [23–26] and are now a commonly used CD4+ T cell line to study HIV-1 latency [27–29], making them an ideal system to investigate TCR/CD3 reactivation response in the context of HIV-1 infection. Here, CD4 is linked to HIV-1 infection.